238 related articles for article (PubMed ID: 26063414)
1. Cleaved high-molecular-weight kininogen inhibits neointima formation following vascular injury.
Daniel JM; Reich F; Dutzmann J; Weisheit S; Teske R; Gündüz D; Bauersachs J; Preissner KT; Sedding DG
Thromb Haemost; 2015 Aug; 114(3):603-13. PubMed ID: 26063414
[TBL] [Abstract][Full Text] [Related]
2. Regulator of G-Protein Signaling 5 Prevents Smooth Muscle Cell Proliferation and Attenuates Neointima Formation.
Daniel JM; Prock A; Dutzmann J; Sonnenschein K; Thum T; Bauersachs J; Sedding DG
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):317-27. PubMed ID: 26663397
[TBL] [Abstract][Full Text] [Related]
3. Epac1 Deficiency Attenuated Vascular Smooth Muscle Cell Migration and Neointimal Formation.
Kato Y; Yokoyama U; Yanai C; Ishige R; Kurotaki D; Umemura M; Fujita T; Kubota T; Okumura S; Sata M; Tamura T; Ishikawa Y
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2617-25. PubMed ID: 26427796
[TBL] [Abstract][Full Text] [Related]
4. Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia.
Ashino T; Yamamoto M; Yoshida T; Numazawa S
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):760-8. PubMed ID: 23413426
[TBL] [Abstract][Full Text] [Related]
5. MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation.
Schlosser A; Pilecki B; Hemstra LE; Kejling K; Kristmannsdottir GB; Wulf-Johansson H; Moeller JB; Füchtbauer EM; Nielsen O; Kirketerp-Møller K; Dubey LK; Hansen PB; Stubbe J; Wrede C; Hegermann J; Ochs M; Rathkolb B; Schrewe A; Bekeredjian R; Wolf E; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Lindholt JS; Holmskov U; Sorensen GL
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):122-33. PubMed ID: 26564819
[TBL] [Abstract][Full Text] [Related]
6. BET bromodomain-containing epigenetic reader proteins regulate vascular smooth muscle cell proliferation and neointima formation.
Dutzmann J; Haertlé M; Daniel JM; Kloss F; Musmann RJ; Kalies K; Knöpp K; Pilowski C; Sirisko M; Sieweke JT; Bauersachs J; Sedding DG; Gegel S
Cardiovasc Res; 2021 Feb; 117(3):850-862. PubMed ID: 32353113
[TBL] [Abstract][Full Text] [Related]
7. Thrombospondin-4 ablation reduces macrophage recruitment in adipose tissue and neointima and suppresses injury-induced restenosis in mice.
Lv L; Liang W; Ye M; Zhang J; Zhang H; Xue G; Zhang L
Atherosclerosis; 2016 Apr; 247():70-7. PubMed ID: 26868511
[TBL] [Abstract][Full Text] [Related]
8. Roles of vascular endothelial and smooth muscle cells in the vasculoprotective effect of insulin in a mouse model of restenosis.
Mori Y; Gonzalez Medina M; Liu Z; Guo J; Dingwell LS; Chiang S; Kahn CR; Husain M; Giacca A
Diab Vasc Dis Res; 2021; 18(3):14791641211027324. PubMed ID: 34190643
[TBL] [Abstract][Full Text] [Related]
9. Direct Evidence for P2Y2 Receptor Involvement in Vascular Response to Injury.
Agca Y; Qian S; Agca C; Seye CI
J Vasc Res; 2016; 53(3-4):163-171. PubMed ID: 27723650
[TBL] [Abstract][Full Text] [Related]
10. Syndecan-4 deficiency limits neointimal formation after vascular injury by regulating vascular smooth muscle cell proliferation and vascular progenitor cell mobilization.
Ikesue M; Matsui Y; Ohta D; Danzaki K; Ito K; Kanayama M; Kurotaki D; Morimoto J; Kojima T; Tsutsui H; Uede T
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1066-74. PubMed ID: 21330609
[TBL] [Abstract][Full Text] [Related]
11. NFATc1-E2F1-LMCD1-Mediated IL-33 Expression by Thrombin Is Required for Injury-Induced Neointima Formation.
Govatati S; Pichavaram P; Janjanam J; Zhang B; Singh NK; Mani AM; Traylor JG; Orr AW; Rao GN
Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1212-1226. PubMed ID: 31043075
[TBL] [Abstract][Full Text] [Related]
12. Novel role of copper transport protein antioxidant-1 in neointimal formation after vascular injury.
Kohno T; Urao N; Ashino T; Sudhahar V; McKinney RD; Hamakubo T; Iwanari H; Ushio-Fukai M; Fukai T
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):805-13. PubMed ID: 23349186
[TBL] [Abstract][Full Text] [Related]
13. Vascular smooth muscle cell-derived transforming growth factor-β promotes maturation of activated, neointima lesion-like macrophages.
Ostriker A; Horita HN; Poczobutt J; Weiser-Evans MC; Nemenoff RA
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):877-86. PubMed ID: 24526697
[TBL] [Abstract][Full Text] [Related]
14. Zinc finger protein 191 deficiency attenuates vascular smooth muscle cell proliferation, migration, and intimal hyperplasia after endovascular arterial injury.
Lv L; Zhang J; Wang P; Meng Q; Liang W; Zhang L
J Vasc Surg; 2014 Feb; 59(2):500-9. PubMed ID: 23755975
[TBL] [Abstract][Full Text] [Related]
15. C1q/TNF-related protein 1 prevents neointimal formation after arterial injury.
Kanemura N; Shibata R; Ohashi K; Ogawa H; Hiramatsu-Ito M; Enomoto T; Yuasa D; Ito M; Hayakawa S; Otaka N; Murohara T; Ouchi N
Atherosclerosis; 2017 Feb; 257():138-145. PubMed ID: 28131048
[TBL] [Abstract][Full Text] [Related]
16. Salt-Inducible Kinase 3 Promotes Vascular Smooth Muscle Cell Proliferation and Arterial Restenosis by Regulating AKT and PKA-CREB Signaling.
Cai Y; Wang XL; Lu J; Lin X; Dong J; Guzman RJ
Arterioscler Thromb Vasc Biol; 2021 Sep; 41(9):2431-2451. PubMed ID: 34196217
[TBL] [Abstract][Full Text] [Related]
17. Association of Serum HMGB2 Levels With In-Stent Restenosis: HMGB2 Promotes Neointimal Hyperplasia in Mice With Femoral Artery Injury and Proliferation and Migration of VSMCs.
He YH; Wang XQ; Zhang J; Liu ZH; Pan WQ; Shen Y; Zhu ZB; Wang LJ; Yan XX; Yang K; Zhang RY; Shen WF; Ding FH; Lu L
Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):717-729. PubMed ID: 28183701
[TBL] [Abstract][Full Text] [Related]
18. DNA-dependent protein kinase (DNA-PK) permits vascular smooth muscle cell proliferation through phosphorylation of the orphan nuclear receptor NOR1.
Medunjanin S; Daniel JM; Weinert S; Dutzmann J; Burgbacher F; Brecht S; Bruemmer D; Kähne T; Naumann M; Sedding DG; Zuschratter W; Braun-Dullaeus RC
Cardiovasc Res; 2015 Jun; 106(3):488-97. PubMed ID: 25852083
[TBL] [Abstract][Full Text] [Related]
19. Time-course analysis on the differentiation of bone marrow-derived progenitor cells into smooth muscle cells during neointima formation.
Daniel JM; Bielenberg W; Stieger P; Weinert S; Tillmanns H; Sedding DG
Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):1890-6. PubMed ID: 20576944
[TBL] [Abstract][Full Text] [Related]
20. PDE4 inhibition reduces neointima formation and inhibits VCAM-1 expression and histone methylation in an Epac-dependent manner.
Lehrke M; Kahles F; Makowska A; Tilstam PV; Diebold S; Marx J; Stöhr R; Hess K; Endorf EB; Bruemmer D; Marx N; Findeisen HM
J Mol Cell Cardiol; 2015 Apr; 81():23-33. PubMed ID: 25640159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
